Drug profile · INN
fluticasone furoate + vilanterol
BREO ELLIPTA 100/25
fluticasone furoate + vilanterol (BREO ELLIPTA 100/25) is an FDA-listed pharmaceutical active ingredient. Associated with GlaxoSmithKline.
TGA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — fluticasone furoate + vilanterol
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
fluticasone furoate + vilanterol (BREO ELLIPTA 100/25) is an FDA-listed pharmaceutical active ingredient. Associated with GlaxoSmithKline.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is fluticasone furoate + vilanterol?
fluticasone furoate + vilanterol (BREO ELLIPTA 100/25) is an FDA-listed pharmaceutical active ingredient. Associated with GlaxoSmithKline.
What is the brand name for fluticasone furoate + vilanterol?
BREO ELLIPTA 100/25 is a marketed brand name for fluticasone furoate + vilanterol. Check FDA Drugs@FDA for the current US label holder and prescribing information.